Mark J. Messing
Oncology | Obstetrics and Gynecology
1001 12th Avenue
Suite 200
Fort Worth, TX 76104
Suite 200
Fort Worth, TX 76104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.
Journal: Journal for immunotherapy of cancer
Published: December 04, 2023
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 06, 2023
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 14, 2020
Showing 1-3 of 3
Last Updated: 09/26/2026